Cargando…

Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma

OBJECTIVE: The study aims to explore the possibility of prelaryngeal and/or pretracheal lymph node metastasis in identifying papillary thyroid carcinoma with more than 5 metastatic central lymph nodes from unilateral lobe cT1-2N0 papillary thyroid carcinoma. METHODS: A retrospective analysis was con...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin, Zhu, Chun-Rong, Fei, Yuan, Liu, Hong, Yao, Xin-Min, Wu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140489/
https://www.ncbi.nlm.nih.gov/pubmed/37124749
http://dx.doi.org/10.3389/fendo.2023.1156664
_version_ 1785033171810648064
author Wang, Bin
Zhu, Chun-Rong
Fei, Yuan
Liu, Hong
Yao, Xin-Min
Wu, Jian
author_facet Wang, Bin
Zhu, Chun-Rong
Fei, Yuan
Liu, Hong
Yao, Xin-Min
Wu, Jian
author_sort Wang, Bin
collection PubMed
description OBJECTIVE: The study aims to explore the possibility of prelaryngeal and/or pretracheal lymph node metastasis in identifying papillary thyroid carcinoma with more than 5 metastatic central lymph nodes from unilateral lobe cT1-2N0 papillary thyroid carcinoma. METHODS: A retrospective analysis was conducted on patients who underwent the initial thyroid surgery for unilateral lobe cT1-2N0 PTC in a single tertiary center between July 2018 to December 2022. Multivariable binary logistic regression analysis was used to identify risk factors for unilateral lobe cT1-2N0 papillary thyroid carcinoma with more than 5 metastatic central lymph nodes. RESULTS: A total of 737 patients were included in the study and 399 patients were confirmed to suffer from occult central lymph node metastasis. The larger size of the largest diameter of tumor (> 1cm; OR = 3.3, 95%CI 1.6 – 6.83; p = 0.001), pretracheal lymph node metastasis (OR = 5.91, 95%CI 2.73 – 12.77; p < 0.001), prelaryngeal lymph node metastasis (OR = 3.74, 95%CI 1.73 – 8.1; p = 0.001), ipsilateral paratracheal lymph node metastasis (OR = 12.22, 95%CI 3.43 – 43.48; p < 0.001), and contralateral paratracheal lymph node metastasis (OR = 7.68, 95%CI 3.86 – 15.3; p < 0.001) were confirmed to be risk factors for unilateral lobe cT1-2N0 PTC with more than 5 metastatic central lymph nodes. When more than two metastatic prelaryngeal and/or pretracheal lymph nodes occurred, the incidence of more than 5 metastatic central lymph nodes was 71.2%. CONCLUSION: Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with more than 5 metastatic central lymph nodes from unilateral lobe cT1-2N0 papillary thyroid carcinoma. When more than two metastatic pretracheal and/or prelaryngeal lymph nodes occurred, total thyroidectomy and ipsilateral central lymph node dissection should be performed and contralateral paratracheal lymph node dissection might be also necessary.
format Online
Article
Text
id pubmed-10140489
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101404892023-04-29 Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma Wang, Bin Zhu, Chun-Rong Fei, Yuan Liu, Hong Yao, Xin-Min Wu, Jian Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: The study aims to explore the possibility of prelaryngeal and/or pretracheal lymph node metastasis in identifying papillary thyroid carcinoma with more than 5 metastatic central lymph nodes from unilateral lobe cT1-2N0 papillary thyroid carcinoma. METHODS: A retrospective analysis was conducted on patients who underwent the initial thyroid surgery for unilateral lobe cT1-2N0 PTC in a single tertiary center between July 2018 to December 2022. Multivariable binary logistic regression analysis was used to identify risk factors for unilateral lobe cT1-2N0 papillary thyroid carcinoma with more than 5 metastatic central lymph nodes. RESULTS: A total of 737 patients were included in the study and 399 patients were confirmed to suffer from occult central lymph node metastasis. The larger size of the largest diameter of tumor (> 1cm; OR = 3.3, 95%CI 1.6 – 6.83; p = 0.001), pretracheal lymph node metastasis (OR = 5.91, 95%CI 2.73 – 12.77; p < 0.001), prelaryngeal lymph node metastasis (OR = 3.74, 95%CI 1.73 – 8.1; p = 0.001), ipsilateral paratracheal lymph node metastasis (OR = 12.22, 95%CI 3.43 – 43.48; p < 0.001), and contralateral paratracheal lymph node metastasis (OR = 7.68, 95%CI 3.86 – 15.3; p < 0.001) were confirmed to be risk factors for unilateral lobe cT1-2N0 PTC with more than 5 metastatic central lymph nodes. When more than two metastatic prelaryngeal and/or pretracheal lymph nodes occurred, the incidence of more than 5 metastatic central lymph nodes was 71.2%. CONCLUSION: Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with more than 5 metastatic central lymph nodes from unilateral lobe cT1-2N0 papillary thyroid carcinoma. When more than two metastatic pretracheal and/or prelaryngeal lymph nodes occurred, total thyroidectomy and ipsilateral central lymph node dissection should be performed and contralateral paratracheal lymph node dissection might be also necessary. Frontiers Media S.A. 2023-04-14 /pmc/articles/PMC10140489/ /pubmed/37124749 http://dx.doi.org/10.3389/fendo.2023.1156664 Text en Copyright © 2023 Wang, Zhu, Fei, Liu, Yao and Wu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wang, Bin
Zhu, Chun-Rong
Fei, Yuan
Liu, Hong
Yao, Xin-Min
Wu, Jian
Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
title Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
title_full Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
title_fullStr Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
title_full_unstemmed Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
title_short Prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe cT1-2N0 papillary thyroid carcinoma
title_sort prelaryngeal and/or pretracheal lymph node metastasis could help to identify papillary thyroid carcinoma with intermediate risk from unilateral lobe ct1-2n0 papillary thyroid carcinoma
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140489/
https://www.ncbi.nlm.nih.gov/pubmed/37124749
http://dx.doi.org/10.3389/fendo.2023.1156664
work_keys_str_mv AT wangbin prelaryngealandorpretracheallymphnodemetastasiscouldhelptoidentifypapillarythyroidcarcinomawithintermediateriskfromunilaterallobect12n0papillarythyroidcarcinoma
AT zhuchunrong prelaryngealandorpretracheallymphnodemetastasiscouldhelptoidentifypapillarythyroidcarcinomawithintermediateriskfromunilaterallobect12n0papillarythyroidcarcinoma
AT feiyuan prelaryngealandorpretracheallymphnodemetastasiscouldhelptoidentifypapillarythyroidcarcinomawithintermediateriskfromunilaterallobect12n0papillarythyroidcarcinoma
AT liuhong prelaryngealandorpretracheallymphnodemetastasiscouldhelptoidentifypapillarythyroidcarcinomawithintermediateriskfromunilaterallobect12n0papillarythyroidcarcinoma
AT yaoxinmin prelaryngealandorpretracheallymphnodemetastasiscouldhelptoidentifypapillarythyroidcarcinomawithintermediateriskfromunilaterallobect12n0papillarythyroidcarcinoma
AT wujian prelaryngealandorpretracheallymphnodemetastasiscouldhelptoidentifypapillarythyroidcarcinomawithintermediateriskfromunilaterallobect12n0papillarythyroidcarcinoma